1. Pharmacogenetic determinants of mercaptopurine disposition in children with acute lymphoblastic leukemia

   • Tiphaine Adam de Beaumais
   • Evelyne Jacqz-Aigrain

   Review Article 16 March 2012 Pages: 1233 - 1242

   

2. Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review

   • Sepideh Elyasi
   • Hossein Khalili
   • Amirhooshang Mohammadpour

   Review Article 13 March 2012 Pages: 1243 - 1255

3. Entry-into-humans study with a new direct renin inhibitor

   • Laurent B. Nicolas
   • Marcelo M. Gutierrez
   • Jasper Dingemanse

   Clinical Trial 15 March 2012 Pages: 1257 - 1266

   

4. CYP2C19 polymorphism affects single-dose pharmacokinetics of oral pantoprazole in healthy volunteers

   • Barbara Gawrońska-Szklarz
   • Urszula Adamiak-Giera
   • Marek Drozdzik

   Pharmacogenetics Open access 15 March 2012 Pages: 1267 - 1274

   

5. Effect of clarithromycin and fluconazole on the pharmacokinetics of montelukast in human volunteers

   • Sahar K. Hegazy
   • Mokhtar M. Mabrouk
   • Noha O. Mansour

   Pharmacokinetics and Disposition 06 March 2012 Pages: 1275 - 1280

   

6. The dopaminergic stabilizer pridopidine is to a major extent N-depropylated by CYP2D6 in humans

   • A. Helldén
   • G. Panagiotidis
   • L. Bertilsson

   Pharmacokinetics and Disposition 08 March 2012 Pages: 1281 - 1286

   

7. Itraconazole and domperidone: a placebo-controlled drug interaction study

   • Tsuneaki Yoshizato
   • Tsutomu Kotegawa
   • Kyoichi Ohashi

   Pharmacokinetics and Disposition 15 March 2012 Pages: 1287 - 1294

   

8. Use of antidepressant agents and the risk of type 2 diabetes

   • S. Khoza
   • J. C. Barner
   • J. P. Wilson

   Pharmacoepidemiology and Prescription 26 November 2011 Pages: 1295 - 1302

9. Variability of antimicrobial prescribing in patients with acute cellulitis

   • Matthew S. Davies
   • Munro B. Robertson
   • W. Stephen Waring

   Pharmacoepidemiology and Prescription 06 March 2012 Pages: 1303 - 1307

10. Modelling drug-related morbidity in Sweden using an expert panel of physicians

    • Katja M. Hakkarainen
    • Daniel Alström
    • Hanna Gyllensten

    Pharmacoepidemiology and Prescription 06 March 2012 Pages: 1309 - 1319

    

11. Healthcare providers’ experiences with adverse drug reactions and adherence challenges in antiretroviral therapy of HIV patients in the Eastern Cape Province, South Africa

    • Karine W. Ruud
    • Sunitha C. Srinivas
    • Else-Lydia Toverud

    Pharmacoepidemiology and Prescription 15 March 2012 Pages: 1321 - 1328

12. Paediatric adverse drug reactions reported to the Spanish Pharmacovigilance System from 2004 to 2009

    • A. Aldea
    • M. García Sánchez-Colomer
    • M. García Sáiz

    Pharmacoepidemiology and Prescription 14 March 2012 Pages: 1329 - 1338

    

13. Prescribing errors intercepted by clinical pharmacists in paediatrics and obstetrics in a tertiary hospital in Spain

    • Cecilia M. Fernandez-Llamazares
    • Miguel-Ángel Calleja-Hernández
    • María Sanjurjo-Sáez

    Pharmacoepidemiology and Prescription 06 March 2012 Pages: 1339 - 1345